High prevalence of GB virus C/hepatitis G virus infection in different risk groups of HIV- infected patients  P. Clevenbergh, J. Durant, P. Halfon, A.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Prevalence of human herpesvirus 8 and hepatitis C virus in a rural community with a high risk for blood-borne infections in central China  T. Zhang, N.
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Atypical respiratory pathogens
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Infectious causes of cancer: an evolving educational saga
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
R. Cantón  Clinical Microbiology and Infection 
Hydatid disease Clinical Microbiology and Infection
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Prevalence of Toscana virus antibodies in residents of Croatia
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence,
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
Cephalosporins: a pharmacological update
Retrospective study of CMV retinitis in patients with AIDS
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
Sepsis and neutropenia induced by clozapine
Gastrointestinal and respiratory Mycobacterium avium colonization and development of disseminated infection in HIV-positive patients  Giampietro Nardi,
Uncommon opportunistic fungi: new nosocomial threats
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Hepatitis B and C virus-related carcinogenesis
Laboratory diagnosis of Clostridium difficile disease
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
A. Bryskier  Clinical Microbiology and Infection 
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Training in infectious diseases and tropical medicine in Britain
Fibronectin concentrations in catheter sepsis
Clinical infection services—the Leiden experience
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Statin use and clinical outcomes among pneumonia patients
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
Overview of cefixime use in community-acquired infections
A. Norberg, C.E. Nord, B. Evengård  Clinical Microbiology and Infection 
Tuberculosis in HIV-infected patients: a comprehensive review
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos 
G.C. Schito  Clinical Microbiology and Infection 
Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip  M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,
New patterns of HIV-1 resistance during HAART
Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies  J.C. Martín, V Soriano,
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Localized Mycobacterium avium complex infection in a patient on HAART
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

High prevalence of GB virus C/hepatitis G virus infection in different risk groups of HIV- infected patients  P. Clevenbergh, J. Durant, P. Halfon, A. Tran, T. Manos, V. Rahelinirina, G. Yang, S. Benzaken, D. Ouzan, P. Rampal, P Dellamonica  Clinical Microbiology and Infection  Volume 4, Issue 11, Pages 644-647 (November 1998) DOI: 10.1111/j.1469-0691.1998.tb00347.x Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Prevalence of anti-E2 and HGV-RNA in HIV-infected patients and healthy blood donors. Clinical Microbiology and Infection 1998 4, 644-647DOI: (10.1111/j.1469-0691.1998.tb00347.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.